File Name: systemic lupus erythematosus and lupus nephritis .zip
- What is lupus?
- Systemic Lupus Erythematosus, Its Treatment, and Future Directions
- Systemic Lupus Erythematosus (SLE)
- Lupus Nephritis
Systemic lupus erythematosus SLE is a heterogeneous autoimmune disease that represents a prodigious challenge of diagnosis and treatment.
What is lupus?
If you're attending our Virtual Advocacy Summit, log in at lupus. Lupus is a chronic long-term disease that can cause inflammation and pain in any part of your body. Learn more about lupus signs and symptoms. Inflammation usually happens when your immune system is fighting an infection or an injury. When lupus makes your immune system attack healthy tissue, it can cause inflammation in lots of different body parts.
Systemic Lupus Erythematosus, Its Treatment, and Future Directions
Systemic lupus erythematosus SLE is a complex, multisystem autoimmune disease which results from the interplay of environmental, hormonal and genetic factors. In children, the presentation, clinical course and immunological findings differ slightly from adults with SLE 1. In the last decade the outcome of SLE patients have improved remarkably, but even though many diagnostic and treatment options are similar for adults and children there are special issues that need to be considered in children and adolescents with SLE. For example, pSLE tends to be more severe and have higher impact on school adjustment and psychosocial aspects related, among others, to physical appearance and growth retardation 2. It is more common in females than in males, with a female to male ratio varying from 2.
Systemic Lupus Erythematosus (SLE)
Systemic lupus erythematosus SLE is commonly called lupus. Lupus nephritis is one of the most serious complications of lupus. It occurs when SLE causes your immune system to attack your kidneys — specifically, the parts of your kidney that filter your blood for waste products. They remove waste from your blood.
Systemic lupus erythematosus SLE , is the most common type of lupus. SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs.
Suzanne Wilhelmus, Ingeborg M. Bajema, George K. Bertsias, Dimitrios T. In the past years, many randomized trials have been performed comparing the treatment strategies for lupus nephritis. In , these data were incorporated in six different guidelines for treating lupus nephritis. These guidelines are European, American and internationally based, with one separate guideline for children.
Lupus nephritis LN remains the most important predictor of morbidity and mortality for patients with SLE. Patients with proteinuria, active urinary sediment, or decreased effective glomerular filtration rate eGFR without other explanation should undergo a kidney biopsy to determine the histologic class and chronicity of LN to guide therapy. In general, we advocate initial treatment of proliferative lupus nephritis with intravenous IV cyclophosphamide according to the Euro-Lupus regimen. Recent maintenance trials in LN report an increased proportion of patients achieving complete remission and fewer renal flares with this approach.
Systemic lupus erythematosus is a multisystem autoimmune disease that commonly Lupus nephritis (LN) is the most common cause of kidney injury in systemic guidelines, proteinuria is the most important clinical var-.
Metrics details. Systemic lupus erythematosus SLE is a systemic autoimmune disease with diverse manifestations. Lupus nephritis is a dreaded complication of SLE as it is associated with significant morbidity and mortality. Advancing the treatment of lupus nephritis requires well-designed clinical trials and this can be challenging in SLE.